Israel Active

On the first ever state visit to Israel, the President Ernest Bai Koroma of the Muslim-majority Sierra Leone expressed his gratitude for the Jewish state’s assistance in fighting the Ebola virus.  “That we have put the Ebola behind us is because of the support of this nation” he said.

Professor Haim Sompolinsky of the Hebrew University in Jerusalem won Israel’s EMET prize for Excellence in Life Sciences (Brain Research) for his work on the principles of brain function and the behavior of neuronal networks, and for shaping brain theories into a systematic discipline.

Magen David Adom, Israel’s national emergency service, has developed the My MDA app. It provides dispatchers and ambulance teams with advance information, including the exact location of the user, medical information, and photos or a live video feed from the scene.

I reported previously about Israel’s P-Cure which has developed low-cost Proton radiation therapy devices to kill cancer tumors.  The revolutionary technology was explained recently on ILTV daily.

I reported previously about HyperQ from Israel’s Biological Signal Processing (BSP) that discovers heart problems that normal ECG tests cannot. BSP’s CEO Dr Yair Granot came on ILTV Daily and said HyperQ had been sold worldwide, including to anti-Israel Venezuela!

A new study in Austria has confirmed the anti-diabetic properties of the purslane herb extract Portulaca oleracea L. Israel’s Frutarom manufactures Portusana®, a scientifically supported and unique purslane extract.

Israel’s Moebius Medical is developing MM-II, a novel treatment for osteoarthritis pain. MM-II’s proprietary liposomes lubricate arthritic knee joints, to reduce friction and wear, and pain in the joints. Moebius has contracted with India's Sun Pharmaceutical to further develop MM-II.

Weizmann Institute scientists have discovered that some viruses (phages) secrete small molecules that are read and updated by other copies of the same virus.  Viruses use this to coordinate their attack and will go dormant if these molecules indicate that insufficient uninfected host cells remain.

I reported previously about Israel’s CoreBone which grows ultra-strong bone-graft material in the laboratory from corals.  CoreBone recently received both CE and ISO 13485 certification to allow the company to sell the product in Europe.

Israel’s Zebra Medical Vision has launched “Profound” –fast, accurate medical image analysis over the web.  Individuals can upload their medical imaging scans such as CTs and mammograms to Zebra’s online service, and receive an automated analysis for key clinical conditions. In addition, Zebra announced a new algorithm that can increase osteoporosis detection by 50%.